These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 2757732)
1. Inclusion and exclusion clinical criteria to form homogeneous groups of patients in the therapeutic trials of a memory enhancing drug. Piette F Arch Gerontol Geriatr Suppl; 1989; 1():195-200. PubMed ID: 2757732 [No Abstract] [Full Text] [Related]
2. Clinical trials in memory disorders: objectives and methodology. Alperovitch A Arch Gerontol Geriatr Suppl; 1989; 1():207-14. PubMed ID: 2757734 [No Abstract] [Full Text] [Related]
3. A logical approach to the clinical assessment of cerebro-active drugs. Wertheimer J Arch Gerontol Geriatr Suppl; 1989; 1():201-5. PubMed ID: 2757733 [No Abstract] [Full Text] [Related]
4. Axel Unterbeck on memory, cognition and the development of CNS drugs. Interview by Steve Carney. Unterbeck A Drug Discov Today; 2005 Feb; 10(3):165-8. PubMed ID: 15708528 [No Abstract] [Full Text] [Related]
10. Forgetting and remembering. A star-studded search for memory-enhancing drugs. Marshall E Science; 2004 Apr; 304(5667):36-8. PubMed ID: 15060299 [No Abstract] [Full Text] [Related]
11. [Study methods of drugs in Alzheimer disease]. Dubois B; Stehlé B; Lehner JP; Derouesné C; Bourin M; Lamour Y; Blin O; Jourdain G; Alperovitch A Therapie; 1996; 51(4):444-8. PubMed ID: 8953828 [TBL] [Abstract][Full Text] [Related]
12. Research design issues: antialuminum drug studies in Alzheimer's disease. Shore D; Wyatt RJ Clin Neuropharmacol; 1982 Dec; 5(4):337-43. PubMed ID: 7159877 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer research forum live discussion: can we (should we?) develop "smart drugs" to stave off age-related memory loss? J Alzheimers Dis; 2009; 17(2):449-52. PubMed ID: 19502710 [No Abstract] [Full Text] [Related]
14. Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial. Wong VS Neurology; 2007 Aug; 69(8):809; author reply 809-10. PubMed ID: 17709718 [No Abstract] [Full Text] [Related]
15. Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment. Crook T Psychopharmacol Bull; 1988; 24(1):31-8. PubMed ID: 3290945 [No Abstract] [Full Text] [Related]
16. Drug development in age-related memory disorders. Guez D Arch Gerontol Geriatr Suppl; 1989; 1():191-4. PubMed ID: 2667542 [No Abstract] [Full Text] [Related]
17. Failure of nalmefene and estrogen to improve memory in Alzheimer's disease. Weiss BL Am J Psychiatry; 1987 Mar; 144(3):386-7. PubMed ID: 3548443 [No Abstract] [Full Text] [Related]
18. Long-term administration of oral physostigmine and lecithin improve memory in Alzheimer's disease. Levin HS; Peters BH Ann Neurol; 1984 Feb; 15(2):210. PubMed ID: 6703661 [No Abstract] [Full Text] [Related]